A new approach tomigraine prevention.
Vedana Therapeutics is developing innovative medicines to help patients achieve migraine freedom.
Migraine affects more than one billion people worldwide.
Migraine is a common and disabling neurological condition that extends far beyond headache, affecting nearly every aspect of daily life. Current standard of care, including CGRP targeted medicines, fails to provide adequate disease control for the majority of patients. This leaves a significant unmet need for new therapies that can deliver complete and lasting relief.
#1
cause of disability in young women
40M
patients in the US
>60%
patients are suboptimally controlled
What We’re Building
Novel medicines that go beyond CGRP.
We are developing next generation, long-acting biologics that build upon the success of CGRP therapies by targeting PACAP and other CGRP-independent pathways.
View full pipeline